Cargando…
Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is the most common glomerular etiology of end-stage kidney disease (ESKD). Increasing evidence has indicated the reparative potential of mesenchymal stem cells (MSCs) in damaged diseased kidneys. However, the effect of bone marrow mesenchymal ste...
Autores principales: | Yang, Ru-chun, Zhu, Xiao-ling, Wang, Jun, Wan, Feng, Zhang, Hua-qin, Lin, Yi, Tang, Xuan-li, Zhu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249725/ https://www.ncbi.nlm.nih.gov/pubmed/30466397 http://dx.doi.org/10.1186/s12882-018-1137-5 |
Ejemplares similares
-
Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis
por: Hu, Qiong-Dan, et al.
Publicado: (2023) -
Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007) -
Pathophysiology of focal segmental glomerulosclerosis
por: Reidy, Kimberly, et al.
Publicado: (2007) -
Pathogenesis of Focal Segmental Glomerulosclerosis
por: Lim, Beom Jin, et al.
Publicado: (2016) -
Unwinding focal segmental glomerulosclerosis
por: Peev, Vasil, et al.
Publicado: (2017)